Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medical Aids and Appliances

Dáil Éireann Debate, Thursday - 19 February 2026

Thursday, 19 February 2026

Ceisteanna (678)

Pádraig Rice

Ceist:

678. Deputy Pádraig Rice asked the Minister for Health further to Parliamentary Question No. 351 of 10 December 2025, to respond to correspondence from HIQA which clearly states that criteria used in their Health Technology Assessment (HTA) of continuous glucose monitoring (CGM) was not limited to patients with type 1 diabetes mellitus who have required insulin from the outset (details supplied); the steps she will take to address this discrepancy; if this reimbursement decision will be revisited; and if she will make a statement on the matter. [13941/26]

Amharc ar fhreagra

Freagraí scríofa

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Roinn